Balyasny Asset Management
GMED icon

Balyasny Asset Management’s Globus Medical GMED Stock Holding History

Balyasny Asset Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.47M Buy
+63,487
New +$5.7M 0.01% 1332
2025
Q2 		– Sell
-4,969
Closed -$364K – 3016
2025
Q1 		$364K Buy
+4,969
New +$411K ﹤0.01% 2381
2024
Q1 		– Sell
-6,800
Closed -$362K – 2804
2023
Q4 		$362K Sell
6,800
-505,672
-99% -$24.6M ﹤0.01% 2090
2023
Q3 		$25.4M Buy
512,472
+292,001
+132% +$16.3M 0.05% 493
2023
Q2 		$13.1M Sell
220,471
-282,039
-56% -$16.1M 0.03% 665
2023
Q1 		$28.5M Buy
+502,510
New +$32.2M 0.07% 404
2022
Q2 		– Sell
-444,610
Closed -$32.8M – 2903
2022
Q1 		$32.8M Buy
444,610
+121,620
+38% +$8.45M 0.1% 260
2021
Q4 		$23.3M Buy
322,990
+124,486
+63% +$9.04M 0.08% 351
2021
Q3 		$15.2M Buy
198,504
+31,751
+19% +$2.55M 0.06% 418
2021
Q2 		$12.9M Sell
166,753
-161,648
-49% -$11.5M 0.06% 423
2021
Q1 		$20.3M Buy
328,401
+256,696
+358% +$16.3M 0.1% 277
2020
Q4 		$4.68M Buy
+71,705
New +$4.12M 0.03% 672
2020
Q1 		– Sell
-418,701
Closed -$24.7M – 1279
2019
Q4 		$24.7M Buy
418,701
+383,018
+1,073% +$20.8M 0.15% 212
2019
Q3 		$1.82M Buy
35,683
+9,379
+36% +$447K 0.01% 728
2019
Q2 		$1.11M Buy
+26,304
New +$1.14M 0.01% 1046
2018
Q4 		– Sell
-7,832
Closed -$445K – 1517
2018
Q3 		$445K Sell
7,832
-99,235
-93% -$5.22M ﹤0.01% 1412
2018
Q2 		$5.4M Sell
107,067
-229,813
-68% -$12M 0.02% 640
2018
Q1 		$16.8M Buy
336,880
+244,932
+266% +$11.5M 0.07% 376
2017
Q4 		$3.78M Buy
91,948
+80,074
+674% +$2.8M 0.01% 948
2017
Q3 		$353K Buy
+11,874
New +$363K ﹤0.01% 1465
2017
Q2 		– Sell
-54,496
Closed -$1.61M – 1560
2017
Q1 		$1.61M Buy
+54,496
New +$1.49M 0.01% 963
2013
Q3 		– Sell
-108,462
Closed -$1.83M – 619
2013
Q2 		$1.83M Buy
+108,462
New +$1.67M 0.03% 447

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Balyasny Asset Management's GMED Position: Q1 2026 in Review

Balyasny Asset Management opened a new position in Globus Medical (GMED) in Q1 2026: 63,487 shares worth $5.47M. The stake represents 0.01% of the portfolio and ranks #1332 among its holdings. This is a return to the name: Balyasny Asset Management previously reported a position in GMED as recently as Q1 2025.

Balyasny Asset Management first reported a position in GMED in Q2 2013 and has held it in 22 quarters since. The position peaked at $32.8M in Q1 2022. 603 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Balyasny Asset Management held 63,487 shares of Globus Medical worth $5.47M as of Q1 2026.
  • Globus Medical was a new Balyasny Asset Management position in Q1 2026.
  • Globus Medical made up 0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #1332 holding.
  • Balyasny Asset Management first reported a position in Globus Medical in Q2 2013 and has held it in 22 quarters since.
  • Balyasny Asset Management's Globus Medical position peaked at $32.8M in Q1 2022.
  • 603 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.